|
|
|||
| |||||||||||||||||||||||||||||||
Each year more than 50,000 people in the United States receive the diagnosis of a benign or malignant tumor of the head and neck. Head and neck cancers are usually curable when they are detected at an early stage, but all too many patients present with advanced lesions, from which they often die. Most survivors of advanced head and neck cancers have long-lasting sequelae that alter their ability to speak and swallow as well as their appearance. Even the treatment of benign head and neck neoplasms may engender considerable functional or cosmetic changes. Patients and their physicians often experience considerable
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |